Zhao et al. (2020) reported EGCG anti‐tumor effects in GC by reducing cell proliferation and migration via modulation of long non‐coding RNA, LINC00511, and the miR‐29b/KDM2A axis. The gene discussed is KDM2A; the disease is gastric cancer.